CareMax Inc. (CMAX) De Novo Tour First Impressions - Piper Sandler
Tweet Send to a Friend
Piper Sandler analyst Jessica Tassan reiterated an Overweight rating and $14.00 price target on CareMax Inc. (NASDAQ: CMAX) after touring ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
